Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.
暂无分享,去创建一个
R. Haché | Y. Lefebvre | Jihong Chen | Qiao Li | Anna Su | R. Hache
[1] D. DeFranco,et al. Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking , 2002, Molecular and Cellular Biology.
[2] Melissa A. Wilson,et al. The Histone Deacetylase Inhibitor Trichostatin A Blocks Progesterone Receptor-mediated Transactivation of the Mouse Mammary Tumor Virus Promoter in Vivo * , 2002, The Journal of Biological Chemistry.
[3] L. Sheldon,et al. Steroid Hormone Receptor-mediated Histone Deacetylation and Transcription at the Mouse Mammary Tumor Virus Promoter* , 2001, The Journal of Biological Chemistry.
[4] A. Caudy,et al. Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.
[5] Jianqi Yang,et al. Sodium Butyrate Induces Transcription from the Gαi2Gene Promoter through Multiple Sp1 Sites in the Promoter and by Activating the MEK-ERK Signal Transduction Pathway* , 2001, The Journal of Biological Chemistry.
[6] K. Yamamoto,et al. Continuous recycling: a mechanism for modulatory signal transduction. , 2001, Trends in biochemical sciences.
[7] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[8] L. Kedes,et al. Proteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription , 2000, Molecular and Cellular Biology.
[9] J. Peters,et al. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. , 2000, Genes & development.
[10] R. Conaway,et al. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Gorbea,et al. Regulation of the 26S proteasome by adenovirus E1A , 2000, The EMBO journal.
[12] C. Pickart,et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] Li Zhao,et al. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. O’Malley,et al. The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .
[15] M. Tyers,et al. Transcriptional regulation: Kamikaze activators , 2000, Current Biology.
[16] C. Lange,et al. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Gilman,et al. Proteasome‐mediated degradation of transcriptional activators correlates with activation domain potency in vivo , 1999, The EMBO journal.
[18] A. Burny,et al. HIV‐1 Tat transcriptional activity is regulated by acetylation , 1999, The EMBO journal.
[19] R. Klausner,et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Wolffe,et al. p300 stimulates transcription instigated by ligand‐bound thyroid hormone receptor at a step subsequent to chromatin disruption , 1999, The EMBO journal.
[21] R. Evans,et al. Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.
[22] B. O’Malley,et al. Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Evans,et al. A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity , 1999, Cell.
[24] Aaron Ciechanover,et al. The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.
[25] V. Ogryzko,et al. Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.
[26] S. Nordeen,et al. Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration* , 1998, The Journal of Biological Chemistry.
[27] C. Glass,et al. Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.
[28] A. Wolffe,et al. Xenopus NF‐Y pre‐sets chromatin to potentiate p300 and acetylation‐responsive transcription from the Xenopus hsp70 promoter in vivo , 1998, The EMBO journal.
[29] A. Goldberg,et al. Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.
[30] W. Zhang,et al. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. T. Kadonaga,et al. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. , 1998, Genes & development.
[32] C. Glass,et al. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. , 1998, Science.
[33] L. Kedes,et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.
[34] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[35] Dirk Bohmann,et al. Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases , 1997, Science.
[36] Andrew J. Bannister,et al. The TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity , 1996, Cell.
[37] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[38] B. Howard,et al. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.
[39] D. Livingston,et al. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Beato,et al. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[42] B. Howard,et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.
[43] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[44] M. Beato,et al. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. , 1995, The EMBO journal.
[45] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[46] K. Yamamoto,et al. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. , 1993, Science.
[47] P. Yaciuk,et al. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth , 1993, Journal of virology.
[48] G. Hager,et al. Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Cato,et al. Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells , 1988, The Journal of cell biology.
[50] N. Defer,et al. Selective inhibition by sodium butyrate of glucocorticoid-induced tyrosine aminotransferase synthesis in hepatoma tissue-cultured cells. , 1981, European journal of biochemistry.
[51] R. Palmiter,et al. Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones , 1980, Cell.
[52] R. Reeves,et al. Sodium butyrate inhibits histone deacetylation in cultured cells , 1978, Cell.
[53] V. Ingram,et al. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.
[54] A. Wolffe,et al. Thyroid hormone receptor, v-ErbA, and chromatin. , 2000, Vitamins and hormones.
[55] B. O’Malley,et al. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent , 2000, Nature Cell Biology.
[56] S. Nef,et al. microRNAs in the testis: building up male fertility. , 2010, Journal of andrology.